Autoimmune Disease Testing
Detection and identification of autoimmune antibodies
can help with the diagnosis, monitoring and prognosis of disease.
Autoimmune diseases arise from autoimmune responses to self-antigens, whereby the body launches an attack against substances or tissues normally present in the body.
From systemic autoimmune diseases such as Systemic Lupus Erythematosus to organ specific disease such as Hashimoto’s thyroiditis and peripheral neuropathy we offer a range of ELISA based diagnostic assays, whether for screening or down-stream antibody identification.
This range of reliable tests from BÜHLMANN are available to assess disease activity in rheumatoid arthritis, Systemic Lupus Erythematosus (SLE) as well as other various systemic disorders mediated by Circulating Immune Complexes (CIC).
Circulating Immunecomplexes provide useful, clinical information regarding immunopathology, prognosis and follow-up of rheumatic and autoimmune disorders. The BÜHLMANN CIC ELISA is a well-established and widely used assay that provides sensitive results within 2 hours.
Released immediately in response to local inflammation, MRP8/14 (also known as calprotectin) is an early and sensitive inflammation marker, compared to other inflammatory markers that are generated by downstream pathways and require de novo synthesis.
It is an ideal target for monitoring disease activity of Rheumatoid Arthritis.